Aplenzin 348 mg/1

Aplenzin 348 mg is an extended-release tablet containing bupropion hydrobromide, used to aid smoking cessation and manage major depressive disorder. This medication is designed for oral administration and is manufactured by Bausch Health US, LLC.

Aplenzin 348 mg is primarily used to help individuals quit smoking and to manage symptoms of major depressive disorder. Bupropion hydrobromide, the active ingredient, works by affecting certain chemicals in the brain that may be unbalanced in people with these conditions. It is important to follow the guidance of a healthcare provider when considering the use of Aplenzin for these purposes.

Common effects of Aplenzin 348 mg may include dry mouth, nausea, and insomnia. Some users might experience headaches or dizziness. These effects can vary from person to person, and it is advisable to monitor any unusual symptoms and consult a healthcare provider if they persist or worsen.

Aplenzin 348 mg should be handled with care, especially by individuals with a history of seizures, eating disorders, or bipolar disorder. It is important to store the medication in a cool, dry place away from children and pets. Always follow the instructions provided by your healthcare provider regarding the use of this medication.

Aplenzin 348 mg may interact with certain medications, including those that affect brain chemicals, such as antidepressants and antipsychotics. It is also advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.